Stockreport

Rigel Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update [Yahoo! Finance]

Rigel Pharmaceuticals, Inc.  (RIGL) 
Last rigel pharmaceuticals, inc. earnings: 2/27 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.rigel.com
PDF Expanded product portfolio with acquisition of U.S. rights to GAVRETO ® , an FDA approved targeted therapy for the treatment of RET fusion-positive metastatic non-small [Read more]